Given these research gaps, there is an immediate requirement for more comprehensive investigations into the molecular biological mechanisms that govern the regulation of PD‐L1 expression in myeloma cells by chemotherapeutic drugs. This evidence concerns the gene CD274 and plasma cell myeloma.